Say goodbye to missing important articles and hello to effortless financial news tracking. Discover the power of STCK.PRO today! Our real-time financial news database combines trusted sources with easy access, making financial news tracking effortless!
Free forever. Get started!Company Name : |
Applied DNA Sciences |
Exchange : |
NASDAQ |
Industry : |
Cyclic Crude, Intermediate, and Gum and Wood Che |
Sector : |
Manufacturing |
Employees : |
60 |
Headquarters: |
Stony Brook - US |
Website: |
https://adnas.com |
Description : Applied DNA is commercializing LinearDNA™, its proprietary, large-scale polymerase chain reaction ( PCR )-based manufacturing platform that allows for the large-scale production of specific DNA sequences. The LinearDNA platform has utility in the nucleic acid-based in vitro diagnostics and preclinical nucleic acid-based drug development and manufacturing market. The platform is used to manufacture DNA for customers as components of in vitro diagnostic tests and for preclinical nucleic acid-based drug development in the fields of adoptive cell therapies (CAR T and TCR therapies), DNA vaccines (anti-viral and cancer), RNA therapies, clustered regularly interspaced short palindromic repeats (CRISPR) based therapies, and gene therapies. Applied DNA has also established a COVID-19 diagnostic and testing offering that is in the early stages of commercialization and is grounded in the Company s deep expertise in DNA. The LinearDNA platform also has non-biologic applications, such as supply chain security, anti-counterfeiting and anti-theft technology. Key end-markets include textiles, pharmaceuticals and nutraceuticals, and cannabis, among others.
Applied DNA Sciences (APDN)
